Bed Bath & Beyond (NASDAQ:BBBY) Issues Quarterly Earnings Results

Bed Bath & Beyond (NASDAQ:BBBY) posted its quarterly earnings data on Wednesday. The retailer reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.04, RTT News reports. The firm had revenue of $2.57 billion during the quarter, compared to analysts’ expectations of $2.58 billion. Bed Bath & Beyond had a negative net margin of 1.14% and a positive return on equity of 9.77%. The company’s quarterly revenue was down 6.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.32 EPS. Bed Bath & Beyond updated its FY 2019 guidance to $2.11-2.11 EPS.

Bed Bath & Beyond stock traded up $0.08 during midday trading on Wednesday, hitting $11.52. 10,600,150 shares of the stock were exchanged, compared to its average volume of 6,736,862. The firm has a fifty day moving average price of $12.23. Bed Bath & Beyond has a 52 week low of $10.46 and a 52 week high of $20.49. The stock has a market capitalization of $1.48 billion, a PE ratio of 5.62, a PEG ratio of 5.81 and a beta of 1.19. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.88 and a quick ratio of 0.62.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Friday, September 13th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 5.90%. Bed Bath & Beyond’s payout ratio is 33.17%.

Several research analysts have recently issued reports on BBBY shares. KeyCorp raised shares of Bed Bath & Beyond from an “underweight” rating to a “sector weight” rating in a research note on Tuesday, March 26th. Wolfe Research raised shares of TD Ameritrade from an “underperform” rating to a “market perform” rating in a research note on Wednesday, March 27th. ValuEngine lowered shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Zacks Investment Research raised shares of Green Brick Partners from a “sell” rating to a “hold” rating in a research note on Wednesday, April 10th. Finally, UBS Group reaffirmed a “buy” rating and issued a $70.00 target price on shares of Lumentum in a research note on Thursday, April 11th. Five research analysts have rated the stock with a sell rating, fourteen have issued a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. Bed Bath & Beyond has a consensus rating of “Hold” and an average target price of $17.06.

Bed Bath & Beyond Company Profile

Bed Bath & Beyond Inc, together with its subsidiaries, operates a chain of retail stores. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products.

Recommended Story: What is the NASDAQ Stock Market?

Earnings History for Bed Bath & Beyond (NASDAQ:BBBY)

Receive News & Ratings for Bed Bath & Beyond Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bed Bath & Beyond and related companies with MarketBeat.com's FREE daily email newsletter.